AHA comments on ensuring legitimate access to controlled substances

The AHA today responded to a Department of Health and Human Services request for input from health care providers and other stakeholders on ensuring legitimate access to controlled substances, including opioids, while preventing diversion and abuse. The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 calls for HHS’ Office of the Assistant Secretary for Planning and Evaluation to submit a report to Congress on the issue. Among other actions, AHA recommends providing additional support for medical education, training and guidance for non-opioid pain management as well as for state drug courts, which offer justice-involved individuals with substance use disorders the opportunity to enter treatment programs.